Financhill
Back

Biomarin Pharmaceutical 10K Form

Buy
54

BMRN
Biomarin Pharmaceutical

Last Price:
66.06
Seasonality Move:
13.3%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive BMRN News And Ratings

See the #1 stock for the next 7 days that we like better than BMRN

BMRN Financial Statistics

Sales & Book Value

Annual Sales: $2.42B
Cash Flow: $200.31M
Price / Cash Flow: 43.1
Annual Sales: $28.41
Price / Book: 2.33

Profitability

EPS (TTM): 1.67000
Net Income (TTM): $322.29M
Gross Margin: $1.9B
Return on Equity: 6.29%
Return on Assets: 4.69%

Biomarin Pharmaceutical Earnings Forecast

Key Biomarin Pharmaceutical Financial Ratios

  • The Gross Profit Margin over the past 26 years for BMRN is 78.72%.
  • The Selling, General & Administrative Expenses for BMRN have been equal to 38.74% of Gross Profit Margin.
  • The Research & Development expenses have been 30.87% of Revenue.
  • The Interest Expense is 9.99% of Operating Income.
  • The Net Earning history of BMRN is 6.93% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 14 years.

Biomarin Pharmaceutical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BMRN
CUSIP: 09061G
Website: biomarin.com

Debt

Debt-to-Equity Ratio: 0.11
Current Ratio: 4.27
Quick Ratio: 2.39

Price-to-Earnings

Trailing P/E Ratio: 75.91
Forward P/E Ratio: 16.16

BMRN Technical Analysis vs Fundamental Analysis

Buy
54
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy or a Sell?